Literature DB >> 16299329

Specific-pathogen-free pigs as an animal model for studying Chlamydia trachomatis genital infection.

Daisy Vanrompay1, Thi Q T Hoang, Liselotte De Vos, Kristel Verminnen, Taher Harkinezhad, Koen Chiers, Servaas A Morré, Eric Cox.   

Abstract

The purpose of the present study was to evaluate pigs as a large-animal model for female genital infection with two Chlamydia trachomatis human serovar E strains. Sixteen-week-old specific-pathogen-free female pigs (gilts) were intravaginally infected with the trachoma type E reference strain Bour or the urogenital serovar E strain 468. Several conclusions can be drawn from our findings on the pathogenicity of a primary C. trachomatis genital infection in gilts. First of all, we demonstrated that the serovar E strains Bour and 468 could ascend in the genital tract of gilts. The serovar E strains could replicate in the superficial columnar cervical epithelium and in the superficial epithelial layer of the uterus, which are known to be the specific target sites for a C. trachomatis genital infection in women. Second, inflammation and pathology occurred at the replication sites. Third, the organisms could trigger a humoral immune response, as demonstrated by the presence of immunoglobulin M (IgM), IgG, and IgA in both serum and genital secretion samples. Our findings imply that the pig model might be useful for studying the pathology, pathogenesis, and immune response to a C. trachomatis infection of the genital system.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16299329      PMCID: PMC1307099          DOI: 10.1128/IAI.73.12.8317-8321.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  AVID: A global alignment program.

Authors:  Nick Bray; Inna Dubchak; Lior Pachter
Journal:  Genome Res       Date:  2003-01       Impact factor: 9.043

2.  EST-based gene discovery in pig: virtual expression patterns and comparative mapping to human.

Authors:  Christopher K Tuggle; Jon A Green; Carolyn Fitzsimmons; Rami Woods; Randall S Prather; Sergei Malchenko; Bento M Soares; Tamara Kucaba; Keith Crouch; Christina Smith; Dylan Tack; Natalie Robinson; Brian O'Leary; Todd Scheetz; Thomas Casavant; Daniel Pomp; Brad J Edeal; Yuandan Zhang; Max F Rothschild; Kevin Garwood; William Beavis
Journal:  Mamm Genome       Date:  2003-08       Impact factor: 2.957

3.  Elementary-body virus isolated from clinical trachoma in California.

Authors:  L HANNA; P THYGESON; E JAWETZ
Journal:  Science       Date:  1959-11-13       Impact factor: 47.728

Review 4.  Chlamydia vaccines: strategies and status.

Authors:  Joseph U Igietseme; Carolyn M Black; Harlan D Caldwell
Journal:  BioDrugs       Date:  2002       Impact factor: 5.807

Review 5.  Is a Chlamydia vaccine a reality?

Authors:  Gunna Christiansen; Svend Birkelund
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2002-12       Impact factor: 5.237

6.  Vaginal myeloperoxidase and flora in the pig-tailed macaque.

Authors:  A B Lichtenwalner; D L Patton; S J Klebanoff; C M Headley; S L Hillier
Journal:  J Med Primatol       Date:  2000-02       Impact factor: 0.667

7.  Disease outcome subsequent to primary and secondary urogenital infection with murine or human biovars of Chlamydia trachomatis.

Authors:  K H Ramsey; J L DeWolfe; R D Salyer
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

8.  Endometritis: the clinical-pathologic syndrome.

Authors:  Linda O Eckert; Stephen E Hawes; Pål K Wölner-Hanssen; Nancy B Kiviat; Judy N Wasserheit; Jorma A Paavonen; David A Eschenbach; King K Holmes
Journal:  Am J Obstet Gynecol       Date:  2002-04       Impact factor: 8.661

9.  Immunoblotting, ELISA and culture evidence for Chlamydiaceae in sows on 258 Belgian farms.

Authors:  Daisy Vanrompay; Tom Geens; Ann Desplanques; Tran Q T Hoang; L De Vos; Marnix Van Loock; E Huyck; Cora Mirry; Eric Cox
Journal:  Vet Microbiol       Date:  2004-03-26       Impact factor: 3.293

10.  Chlamydia trachomatis serovar E isolates from patients with different clinical manifestations have similar courses of infection in a murine model: host factors as major determinants of C trachomatis mediated pathogenesis.

Authors:  J M Lyons; J I Ito; S A Morré
Journal:  J Clin Pathol       Date:  2004-06       Impact factor: 3.411

View more
  13 in total

Review 1.  Genital Chlamydia trachomatis: understanding the roles of innate and adaptive immunity in vaccine research.

Authors:  Sam Vasilevsky; Gilbert Greub; Denise Nardelli-Haefliger; David Baud
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

Review 2.  Animal models for studying female genital tract infection with Chlamydia trachomatis.

Authors:  Evelien De Clercq; Isabelle Kalmar; Daisy Vanrompay
Journal:  Infect Immun       Date:  2013-07-08       Impact factor: 3.441

3.  Guinea pig genital tract lipidome reveals in vivo and in vitro regulation of phosphatidylcholine 16:0/18:1 and contribution to Chlamydia trachomatis serovar D infectivity.

Authors:  Shradha Wali; Rishein Gupta; Jieh-Juen Yu; Adelphe Mfuh; Xiaoli Gao; M Neal Guentzel; James P Chambers; Sazaly Abu Bakar; Guangming Zhong; Bernard P Arulanandam
Journal:  Metabolomics       Date:  2016-03-08       Impact factor: 4.290

4.  Factors that influence the rate of epithelial maturation in the cervix in healthy young women.

Authors:  Loris Y Hwang; Yifei Ma; Susanna Miller Benningfield; Lisa Clayton; Evelyn N Hanson; Julie Jay; Janet Jonte; Cheryl Godwin de Medina; Anna-Barbara Moscicki
Journal:  J Adolesc Health       Date:  2009-02       Impact factor: 5.012

Review 5.  Chlamydia trachomatis vaccine research through the years.

Authors:  Katelijn Schautteet; Evelien De Clercq; Daisy Vanrompay
Journal:  Infect Dis Obstet Gynecol       Date:  2011-06-26

6.  The vaginal microbiome is stable in prepubertal and sexually mature Ellegaard Göttingen Minipigs throughout an estrous cycle.

Authors:  Emma Lorenzen; Egle Kudirkiene; Nicole Gutman; Anette Blak Grossi; Jørgen Steen Agerholm; Karin Erneholm; Christina Skytte; Marlene Danner Dalgaard; Anders Miki Bojesen
Journal:  Vet Res       Date:  2015-10-28       Impact factor: 3.683

7.  The immune response against Chlamydia suis genital tract infection partially protects against re-infection.

Authors:  Evelien De Clercq; Bert Devriendt; Lizi Yin; Koen Chiers; Eric Cox; Daisy Vanrompay
Journal:  Vet Res       Date:  2014-09-25       Impact factor: 3.683

Review 8.  A review of the human vs. porcine female genital tract and associated immune system in the perspective of using minipigs as a model of human genital Chlamydia infection.

Authors:  Emma Lorenzen; Frank Follmann; Gregers Jungersen; Jørgen S Agerholm
Journal:  Vet Res       Date:  2015-09-28       Impact factor: 3.683

9.  Genital tract lesions in sexually mature Göttingen minipigs during the initial stages of experimental vaginal infection with Chlamydia trachomatis serovar D.

Authors:  Karin Erneholm; Emma Lorenzen; Sarah Bøje; Anja Weinreich Olsen; Peter Andersen; Joseph P Cassidy; Frank Follmann; Henrik E Jensen; Jørgen S Agerholm
Journal:  BMC Vet Res       Date:  2016-09-10       Impact factor: 2.741

10.  A multi-subunit Chlamydia vaccine inducing neutralizing antibodies and strong IFN-γ⁺ CMI responses protects against a genital infection in minipigs.

Authors:  Sarah Bøje; Anja Weinreich Olsen; Karin Erneholm; Jørgen Steen Agerholm; Gregers Jungersen; Peter Andersen; Frank Follmann
Journal:  Immunol Cell Biol       Date:  2015-08-13       Impact factor: 5.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.